content: <PAGE>
  
  ================================================================================
                                   UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
  
                              Washington, D.C.  20549
  
                                __________________
  
                                     FORM 8-K
  
                                  Current Report
      Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  
                                __________________
  
                 Date of Report (Date of earliest event reported):
                                  August 23, 2001
  
                                ___________________
  
                                   VIDAMED, INC.
              (Exact name of registrant as specified in its charter)
  
  
           Delaware                        0-26082                77-0314454
  (State or Other Jurisdiction of  (Commission File Number)    (I.R.S. Employer
         Incorporation)                                     Identification Number)
  
  
       46107 Landing Parkway
        Fremont, California                              94538
  (Address of Principal Executive Offices)             (Zip Code)
  
  
                                  (510) 492-4900
               (Registrant's Telephone Number, Including Area Code)
  
  
                                        N/A
           (Former Name or Former Address, If Changed Since Last Report)
  
  ================================================================================
  <PAGE>
  
  Item 5.  Other Events
  
       On August 23, 2001, VidaMed, Inc. announced that Randy D. Lindholm,
  Chairman, President and Chief Executive Officer of VidaMed, adopted a written
  trading plan pursuant to Rule 10b5-1 under the Securities Act of 1934 that will
  allow him to sell up to 15,000 shares of VidaMed stock a month.  Mr. Lindholm
  currently holds over 2.1 million shares of VidaMed stock, including stock
  options.  A copy of the press release announcing the plan is attached to this
  report as Exhibit 99.1 and is incorporated herein by this reference.
  
  
  Item 7. Financial Statements and Exhibits.
  
          (c)  Exhibits.
  
               Exhibit
                 No.                        Description
               -------          ------------------------------------
                99.1            Press Release issued August 23, 2001
  <PAGE>
  
                                     SIGNATURE
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                             VIDAMED, INC.
  
                             By: /s/ Randy D. Lindholm
                                 ---------------------------
                                     Randy D. Lindholm
                                 Chairman, President and Chief Executive Officer
  
  
  Dated:   August 23, 2001
  <PAGE>
  
                                   VIDAMED, Inc.
  
                                     FORM 8-K
  
                                   Exhibit Index
                                   -------------
  
  
  
   Exhibit
     No.                   Description                       Method of Filing
   -------      ------------------------------------         ----------------
    99.1        Press Release issued August 23, 2001          Filed herewith
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "d8k.txt", "description": "FORM 8-K", "secsgml_size_bytes": 3326}]
metadata_filer: {"company-data": {"conformed-name": "VIDAMED INC", "cik": "0000929900", "assigned-sic": "3841", "irs-number": "770314454", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26082", "film-number": "1722330"}, "business-address": {"street1": "46107 LANDING PARKWAY", "street2": "SUITE 101", "city": "FREMONT", "state": "CA", "zip": "94538", "phone": "5104924900"}, "mail-address": {"street1": "46107 LANDING PARKWAY", "street2": "STE 101", "city": "FREMONT", "state": "CA", "zip": "94538"}}
text: ================================================================================
                                   UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
  
                              Washington, D.C.  20549
  
                                __________________
  
                                     FORM 8-K
  
                                  Current Report
      Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  
                                __________________
  
                 Date of Report (Date of earliest event reported):
                                  August 23, 2001
  
                                ___________________
  
                                   VIDAMED, INC.
              (Exact name of registrant as specified in its charter)
  
           Delaware                        0-26082                77-0314454
  (State or Other Jurisdiction of  (Commission File Number)    (I.R.S. Employer
         Incorporation)                                     Identification Number)
  
       46107 Landing Parkway
        Fremont, California                              94538
  (Address of Principal Executive Offices)             (Zip Code)
  
                                  (510) 492-4900
               (Registrant's Telephone Number, Including Area Code)
  
                                        N/A
           (Former Name or Former Address, If Changed Since Last Report)
  
  ================================================================================
  Item 5.  Other Events
  
       On August 23, 2001, VidaMed, Inc. announced that Randy D. Lindholm,
  Chairman, President and Chief Executive Officer of VidaMed, adopted a written
  trading plan pursuant to Rule 10b5-1 under the Securities Act of 1934 that will
  allow him to sell up to 15,000 shares of VidaMed stock a month.  Mr. Lindholm
  currently holds over 2.1 million shares of VidaMed stock, including stock
  options.  A copy of the press release announcing the plan is attached to this
  report as Exhibit 99.1 and is incorporated herein by this reference.
  
  Item 7. Financial Statements and Exhibits.
  
          (c)  Exhibits.
  
               Exhibit
                 No.                        Description
               -------          ------------------------------------
                99.1            Press Release issued August 23, 2001
  SIGNATURE
  
       Pursuant to the requirements of the Securities Exchange Act of 1934, the
  Registrant has duly caused this report to be signed on its behalf by the
  undersigned hereunto duly authorized.
  
                             VIDAMED, INC.
  
                             By: /s/ Randy D. Lindholm
                                 ---------------------------
                                     Randy D. Lindholm
                                 Chairman, President and Chief Executive Officer
  
  Dated:   August 23, 2001
  VIDAMED, Inc.
  
                                     FORM 8-K
  
                                   Exhibit Index
                                   -------------
  
   Exhibit
     No.                   Description                       Method of Filing
   -------      ------------------------------------         ----------------
    99.1        Press Release issued August 23, 2001          Filed herewith